|Company name||GlaxoSmithKline plc|
|Company type||Public limited company|
|Slogan||"Do more, feel better, live longer"|
|Headquarters||London, United Kingdom|
|Key people||Chris Gent (Chairman)|
Andrew Witty (Chief Executive)
|Products||Central nervous system, respiratory, antiviral, antibiotic, oncology and emesis, metabolic, cardiovascular, urogenital, and over-the-counter medicines; vaccines; oral and nutritional healthcare products|
|Revenue||£28.392 billion (2010)|
|Operating income||£5.128 billion (2010)|
|Net income||£1.853 billion (2010)|
|Employees||99,000 (2009)|| |
GlaxoSmithKline plc (GSK) (Lse - GSK, Nyse - GSK) is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world's third-largest pharmaceutical company measured by revenues (after Johnson & Johnson and Pfizer).
GSK has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions. It also has a large consumer healthcare division which produces and markets oral healthcare and nutritional products and over-the-counter medicines including Sensodyne, Boost, Horlicks and Gaviscon.
GSK has its primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on the New York Stock Exchange.